Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep617 | Pituitary and Neuroendocrinology | ECE2020

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors

Castellnou Solene , Vasiljevic Alexandre , Lapras Veronique , Raverot Véronique , Alix Eudeline , Borson-Chazot Francoise , Jouanneau Emmanuel , Raverot Gerald , Hélène Lasolle

Context: Somatostatin receptor type 5 (SST5) is inconsistently expressed by corticotroph tumors, with higher expression found in corticotropinomas having ubiquitin-specific protease 8 (USP8) mutations.Aims: To study the correlation between characteristics of corticotropinomasand SST5 expression/USP8 mutation status; to describe the response to pasireotide in 5 patients.Design: Retrospective cohort study.Metho...

ea0070aep898 | Thyroid | ECE2020

Age and sex-specific TSH upper-limit reference intervals in the general French population: There is a need to adjust our actual practices

Raverot Véronique , Maxime Bonjour , Juliette Abeillon , Pauline Perrin , Florence Roucher , Hélène Lasolle , Fabien Subtil , Borson-Chazot Francoise

Background: The increasing age of the general population represents a new challenge for endocrinologists and caregivers since it is well know that the occurrence of thyroid dysfunction increases with age. It is still controversial whether or not reference values of thyrotropin (TSH) adapted to age and sex need to be used. Herein, we aimed to determine reference intervals, in males and females, suitable for thyroid disease exploration and follow-up during adult life in a tertia...

ea0029p57 | Adrenal cortex | ICEECE2012

Reevaluation of the 4 mg intravenous dexamethasone suppression test for differentiation of Cushing’s disease from pseudo-Cushing’s syndrome

Nouvel M. , Rabilloud M. , Raverot V. , Pignard C. , Vouillarmet J. , Thivolet C. , Jouanneau E. , Chazot F Borson , Pugeat M. , Raverot G.

Context: Differentiating Cushing’s disease (CD) from pseudo-Cushing’s syndrome (PCS) is one of the most challenging problems since no biological test is yet perfect. Almost 30 years ago our group demonstrated the interest of 4 mg i.v. dexamethasone suppressing test (DST) to differentiate obese patients to CD.Objective: To reevaluate the diagnostic accuracy of the 4 mg i.v. DST in carefully selected patients with PCS and CD.<p class="abstext...